A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: A cluster RCT

University of Texas Health Science Center-Houston, Division of General Internal Medicine, Houston, USA.

We assessed the short-term effects of a community-based intervention for Hispanic men to encourage informed decision making (IDM) about prostate cancer screening with prostate specific antigen (PSA).

All senior social and housing centers in El Paso, TX were randomized to intervention, a group-based Spanish language educational program facilitated by promotores (12 centers; 161 men) [I's], or to control, promotores-facilitated diabetes video and discussion (13 centers; 160 men) [C's].

Participants had low levels of schooling and baseline knowledge; 44% reported previous PSA testing. At post-test, the I's made large knowledge gains, increased their understanding that experts disagree about testing, shifted toward more active decision making roles, were more likely to believe that it is important to weigh the advantages and disadvantages of screening and to anticipate potential screening outcomes in making a decision, and were less likely to consider the screening decision easy. The I's did not change in their screening intention or the belief that choosing not to be screened could be a responsible choice.

A community-based intervention to support IDM for prostate cancer screening can increase knowledge and may promote more active involvement in decision making about prostate cancer screening. Such an approach can increase knowledge and may promote more active involvement in decision making about prostate cancer screening.

It is feasible to develop and implement a community-based intervention program to promote IDM for prostate cancer screening.

Written by:
Chan EC, McFall SL, Byrd TL, Mullen PD, Volk RJ, Ureda J, Calderon-Mora J, Morales P, Valdes A, Kay Bartholomew L.   Are you the author?

Reference: Patient Educ Couns. 2011 Jan 13. Epub ahead of print.
doi: 10.1016/j.pec.2010.07.033

PubMed Abstract
PMID: 21237611

UroToday.com Prostate Cancer Section